Sonnet BioTherapeutics Holdings, Inc. (SONN)

SONN Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 1, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Cap	9	4	5	8	36	76
Market Cap Growth	242.32%	-13.25%	-38.41%	-77.68%	-51.75%	1038.67%
Enterprise Value	8.35	4.33	2.94	5.35	8.98	68.6
Last Close Price	1.26	6.69	22.92	258.46	1491.69	12652.30
PE Ratio	-	-0.59	-0.16	-0.21	-0.59	-0.74
PS Ratio	3.41	233.57	33.93	23.27	75.42	-
PB Ratio	-	-8.96	-22.19	-3.21	1.64	25.03
P/TBV Ratio	-1.12	-9.02	-13.16	-2.51	0.67	16.02
P/FCF Ratio	-	-	-0.23	-0.29	-1.62	-4.82
P/OCF Ratio	-	-	-0.23	-0.29	-1.62	-4.84
EV/Sales Ratio	8.35	232.57	19.92	15.27	18.57	-
EV/EBITDA Ratio	-	-0.37	-0.16	-0.18	-0.36	-2.84
EV/EBIT Ratio	-	-0.37	-0.16	-0.18	-0.36	-2.83
EV/FCF Ratio	-	-	-0.14	-0.19	-0.40	-4.37
Debt / Equity Ratio	-0.02	-0.27	-0.90	-0.10	0.01	0.12
Debt / EBITDA Ratio	0.00	-0.01	-0.01	-0.01	0.00	-0.01
Debt / FCF Ratio	-	-	-0.01	-0.01	-0.01	-0.02
Asset Turnover	-	0.00	0.03	0.02	0.03	0
Quick Ratio	0.18	0.28	0.55	0.46	4.12	1.56
Current Ratio	0.26	0.66	0.86	0.66	4.30	1.62
Return on Equity (ROE)	-3053.85%	2089.93%	1362.37%	-301.42%	-197.66%	36739.16%
Return on Assets (ROA)	-326.04%	-288.99%	-333.81%	-170.40%	-135.65%	-122.64%
Return on Invested Capital (ROIC)	-2232.90%	-1558.83%	-2651.49%	-4153.91%	-2860.72%	-117.51%
Return on Capital Employed (ROCE)	-2970.96%	4435.65%	1546.77%	-297.35%	-196.30%	-290.15%
Earnings Yield	-157.59%	-169.66%	-633.20%	-465.90%	-168.13%	-135.54%
FCF Yield	-119.86%	0.00%	-425.60%	-341.10%	-61.84%	-20.76%
Buyback Yield / Dilution	-	0.00%	-418.92%	-22.62%	-117.47%	-38.18%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q